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A recombinant vaccinia virus encoding rotavirus protein NSP3 driven by an internal ribosome entry site (IRES) from the
encephalomyocarditis (EMC) virus was able to abate protein synthesis in BSC1 cells by 25-fold, with as much as 30% of the
remaining protein synthesis being NSP3. Hence NSP3 shuts off host cell protein synthesis down to the level seen during
rotavirus infection but is unable to prevent translation from EMC IRES-driven genes. This effect was abolished by deletions
in the eIF4G-binding (aa 274–313) and the dimerization (aa 150–206) but not the viral mRNA-binding (aa 83–149) domains,INTRODUCTION
The process of translation initiation has undergone a
major paradigm shift with increasing evidence of mRNA
circularization and its formal proof by atomic force micros-
copy (Wells et al., 1998); however, the importance and func-
tional consequences of mRNA circularization for the full
complement of cellular mRNAs have not been addressed.
Circularization of capped and polyadenylated mRNAs is
mediated by the translation initiation factor eIF4G, a multi-
adaptor platform that brings together the cap-binding pro-
tein eIF4E, the RNA helicase eIF4A, and poly(A)-binding
protein (PABP). These interactions promote translation ini-
tiation via the interaction of eIF4G with eIF3 on the 43S
ribosomal preinitiation complex (Merrick and Hershey,
1996). A critical link of such circular mRNAs, PABP, is
evicted in vitro from eIF4G by the nonstructural rotavirus
protein NSP3, a PABP analog able to bind to eIF4G via its
carboxyterminus, from amino acid 206 to 313 (Piron et al.,
1999), which is thereby able to interfere with 5-3 circular-
ization of capped and polyadenylated mRNAs. On the other
hand, NSP3 specifically binds to the 3-end consensus
sequence UGACC of rotavirus mRNAs (Poncet et al., 1994)
via its aminoterminus from amino acid 4 to 149 (Piron et al.,
1999) and is thereby able to supersede the function of PABP
on viral mRNAs. In addition NSP3 contains a dimerization
domain in the middle part of the protein, between amino
acids 150 and 206, identified by using the two-hybrid sys-
tem in yeast (Piron et al., 1999). In lieu of these properties,
NSP3 has been shown to inhibit protein synthesis of
capped and polyadenylated mRNAs up to 1-fold in vivo, in a
11stably transfected cell line that expresses NSP3, and 10-
fold in vitro (Vende et al., 2000). The modest level of protein
synthesis inhibition achieved in vivo is far from reaching the
shutoff of host cell protein synthesis seen during rotavirus
infection. We aimed at studying the in vivo functional con-
sequences of mRNA circularization using rotavirus protein
NSP3 to interfere with such circularization to establish
whether NSP3 is solely responsible for the shutoff of host
cell protein synthesis seen during rotavirus infection and to
determine if such an effect on the host cell protein synthe-
sis is affected by deletions in each of the three functional
domains identified in NSP3. We chose to express the Rhe-
sus rotavirus (RRV) NSP3 gene using the VOTE (vaccinia
virus/lac operon/T7 RNA polymerase/EMC IRES) mamma-
lian cell expression system (Ward et al., 1995). In this sys-
tem a recombinant vaccinia virus is produced with the
target gene transcribed from a T7 RNA polymerase pro-
moter, regulated by an Escherichia coli lac operator, and
produced in high levels thanks to an internal ribosome
entry site (IRES) of the encephalomyocarditis (EMC) virus.
Even though vaccinia virus itself is able to inhibit host cell
protein synthesis (Su and Bablanian, 1990), vaccinia mR-
NAs are both capped and polyadenylated (Moss, 2001) and
are therefore likely targets for NSP3-mediated protein syn-
thesis inhibition, as are most cellular mRNAs. Incidentally,
the inclusion of an EMC IRES driving the expression of
NSP3 in the vaccinia vector allowed us to evaluate the in
vivo consequences of interfering with the PABP-mediated
5-3 mRNA circularization in the expression of a gene
containing the EMC IRES.
RESULTSsupporting that NSP3 functions in vivo as a dimer. Binding
5-3 circularization, hence such circularization is essentia
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virus vT7lacOI to achieve high levels of regulated expres-
sion of the nonstructural rotavirus protein NSP3 of RRV in
mammalian cells, as well as an anti-NSP3 serum to test
the identity of the recombinant protein. Upon infection of
BSC1 cells with vRRV7 and induction with isopropyl-1-
thio--D-galactoside (IPTG), authentic NSP3 was pro-
duced as demonstrated by the ability of the anti-NSP3
serum to precipitate both the protein produced in cells
infected with vaccinia vRRV7 or rotavirus RRV (Fig. 1).
In order to test whether the expression of NSP3 was
indeed regulated we performed extended metabolic la-
beling during 22 h with [35S]methionine in BSC1 cells
infected with vRRV7 in the presence of increasing doses
of the inducer IPTG (Fig. 2). Increasing doses of the
inducer led to an accumulation of NSP3, which repre-
sented 18% of the total proteins synthesized with the
maximum dose of inducer used in Fig. 2 (lane 8). The
high level of expression achieved with the VOTE system
allowed the detection of NSP3 upon long metabolic la-
beling, despite the presence of a 34-kDa protein synthe-
sized in cells infected by the parental vaccinia virus
vT7lacOI, which comigrates with NSP3 (Fig. 2, lane 3). A
second protein of approximately 33 kDa, which is likely
to be a product of degradation of NSP3, could also be
barely detected with the highest doses of the inducer
used in this experiment (Fig. 2, lanes 7 and 8) and was
absent in cells infected with the parental virus. Addition-
ally, and as it was expected, a third protein of the mo-
lecular weight expected for the T7 RNA polymerase (99
kDa) was also present in cells infected by both the
parental and recombinant vaccinia viruses upon induc-
tion with the highest dose of IPTG (Fig. 2, lanes 3 and 8).
We then analyzed the pattern of proteins synthesized
by BSC1 cells late after infection with vRRV7 in response
to different doses of the inducer IPTG, by performing
[35S]methionine pulse labeling at 24 h postinfection (Fig.
3). This experiment was done along with radioimmuno-
precipitation assays (RIPA) with the anti-NSP3 monoclo-
nal antibody PNS31 (L. Padilla-Noriega, unpublished re-
sults) versus the pulse-labeled cell lysates, in order to
differentiate between NSP3 and the 34-kDa protein pro-
duced by the parental vaccinia virus. Increasing doses of
the inducer led to increasing amounts of NSP3 as can be
seen in both the electrophoresis of the pulse-labeled cell
lysates and the corresponding RIPAs with the anti-NSP3
monoclonal antibody (Fig. 3). In contrast to the synthesis
of NSP3, global protein synthesis was progressively re-
duced with increasing doses of the inducer. By densi-
tometry of Fig. 3 we detected that even in the absence of
inducer vRRV7-infected cells (lane 4) yielded just 67% of
the proteins synthesized by the control virus vT7lacOI
(lane 3), and in the presence of 50 M IPTG, the maxi-
mum dose of inducer used in this experiment, the total
protein synthesis was reduced by 10-fold, with NSP3
representing 30% of the remaining protein synthesis
(lane 8). Further experiments with higher doses of the
inducer reached a 25-fold reduction in protein synthesis
in cells infected by vRRV7 with 200 M IPTG (Fig. 4, lane
6) as compared to the parental virus (Fig. 4, lane 4);
however, in such conditions NSP3 represented a lower
percentage of the remanent protein synthesis. Despite
the observed reduction in protein synthesis in cells in-
fected with vRRV7 in the absence of inducer we were
FIG. 2. Demonstration of regulated expression of NSP3 in cells
infected by vRRV7. Extended (22 h) [35S]methionine labeling and PAGE
of BSC1 cells mock-infected (lane 2) or infected with vaccinia viruses
vT7lac OI (lane 3) or vRRV7 (lanes 4–8) in the presence of the indicated
micromolar concentrations of the inducer IPTG. Lane 1 has molecular
weight markers. Solid triangles indicate the localization of the T7 RNA
polymerase.
FIG. 1. Identification of the recombinant NSP3 produced in cells
infected with vRRV7. Radioimmunoprecipitation of hyperimmune anti-
NSP3 serum versus [35S]methionine-labeled BSC1 cells infected with
vaccinia viruses vRRV7 (lane 4) or vT7lacOI (lane 5) or MA104 cells
infected with rotavirus RRV (lane 6) and the corresponding lysates from
cells infected with vRRV7 (lane 2), vT7lacOI (lane 3), and RRV (lane 7).
Lane 1 has molecular weight markers.
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able to detect no measurable amount of NSP3 in such
conditions from densitometric analysis of the metaboli-
cally labeled cell lysate (Fig. 3, lane 4) or the correspond-
ing RIPA (Fig. 3, lane 10) (i.e., NSP3 if present was at a
level below the sensitivity of our detection method). The
99-kDa band presumed to be the T7 RNA polymerase
could be barely detected in induced cells infected by
vT7lacOI (Fig. 3, lane 3) and was undetectable in cells
infected by vRRV7 either uninduced or induced (Fig. 3,
lanes 4 and 8), implicating that the expression of this
protein was also affected by NSP3.
Piron et al. have found by BIAcore analysis that NSP3
binds in vitro to RNA as a dimer and suggested that
despite its inability to dimerize by itself the RNA-binding
domain (aa 4–149) dimerizes upon binding to RNA,
based on gel retardation analysis (Piron et al., 1999). This
hypothesis was fully supported by the recent solving of
the structure of the NSP3 RNA-binding domain (Deo et
al., 2002), which was cocrystallized with its oligoribonu-
cleotide ligand, showing a dimeric protein binding a
single oligoribonucleotide, with an asymmetric contribu-
tion of the two subunits to the RNA-binding site and
intertwining between the monomers. It has similarly
been found by pull-down assays that a fragment of NSP3
lacking the dimerization domain is able to bind to eIF4G
(Piron et al., 1998); however, the importance of dimeriza-
tion for eIF4G binding has not been determined. In order
to ascertain the role of the dimerization, RNA-binding,
and eIF4G-binding domains of NSP3 on host cell protein
synthesis we produced NSP3 deletion mutants in each of
these three domains for expression in the VOTE system.
We used vaccinia virus vRRV7 and its three deletion
mutants, vRRV7-83-149, lacking part of the RNA-binding
domain; vRRV7-150-206, lacking the whole dimerization
domain; and vRRV7-274-313, lacking part of the eIF4G-
binding domain, in pulse labeling experiments 24 h after
infection in the presence or absence of 200 M IPTG
(Fig. 4). Two of the deletion mutants, vRRV7-150-206
and vRRV7-274-313, were able to induce readily the
synthesis of proteins with apparent molecular weights of
28 kDa (NSP3-150-206) (Fig. 2, lane 10) and 32 kDa
(NSP3-274-313) (Fig. 2, lane 12), which correspond to
their expected molecular weights. Additionally, both pro-
duced an extra minor band approximately 1 kDa smaller
than the major recombinant protein, as observed with
wild-type NSP3 expressed by vRRV7. The third mutant,
vRRV7-83-149, necessitated augmenting the dose of
inducer and reducing the time of induction to readily
detect the expected 29-kDa protein (NSP3-83-149) (Fig.
4, lane 13); however, an additional and abundant 25-kDa
protein was also detected, presumably a degradation
product of the recombinant protein. By densitometric
analysis of Fig. 4, we found that both vRRV7 and vRRV7-
83-149 were able to shut down protein synthesis in
BSC1 cells by 25-fold, whereas there was no inhibitory
effect on cellular protein synthesis induced by vRRV7-
150-206 or vRRV7-274-313, hence the shutoff of host
cell protein synthesis by NSP3 requires both the eIF4G-
FIG. 3. Analysis of the proteins synthesized late after infection in cells infected with vRRV7 by PAGE of metabolically labeled cells and RIPA of the
cell lysates with the anti-NSP3 monoclonal antibody PNS31. Metabolic [35S]methionine pulse labeling (lanes 2–8) of BSC1 cells mock-infected (lane
2) or infected with vT7lacOI (lane 3) or with vRRV7 (lanes 4–8) in the presence of the indicated micromolar concentrations of the inducer IPTG.
Radioimmunoprecipitation with the anti-NSP3 monoclonal antibody PNS31 of the [35S]methionine pulse-labeled cell lysates (lanes 9–14) from BSC1
cells infected with vT7lacOI (lane 9) or with vRRV7 (lanes 10–14) in the presence of the indicated micromolar concentrations of the inducer IPTG. Lanes
1 and 15 have molecular weight markers. A solid triangle indicates the localization of the T7 RNA polymerase.
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binding and dimerization domains but not the RNA-bind-
ing domain.
The above experiments were all done in BSC1 cells
from monkey. In order to test if NSP3 is also able to shut
off protein synthesis in cells from other species, we
performed pulse-labeling experiments of human HeLa
cells infected with vRRV7 in response to different doses
of IPTG, obtaining similar results as those obtained with
BSC1 cells (data not shown).
DISCUSSION
We used the VOTE vaccinia system to express the
rotavirus protein NSP3 in mammalian cells whereby the
sole expression of this rotavirus protein resulted in inhi-
bition of the combined protein synthesis of vaccinia plus
the host cell of a magnitude that is comparable to the
one reached in rotavirus infected cells. This result con-
trasts with the modest level of protein synthesis inhibi-
tion achieved in a previous in vivo study (Vende et al.,
2000). The system used by Vende et al. was based on
constitutive NSP3 expression in stably transformed cells,
thereby it is likely that only cells expressing low levels of
this protein could be selected due to its interference with
host cell protein synthesis. The ability of NSP3 alone to
shut off host cell protein synthesis makes it unlikely that
other rotavirus proteins have a role in this viral function.
Moreover, the magnitude of the in vivo effect of NSP3 and
the knowledge that NSP3 evicts PABP from eIF4G and
thereby interferes with 5-3 circularization of capped
and polyadenylated mRNAs implicate that mRNA circu-
larization is essential for translation in mammalian cells.
The protein synthesis that occurs late during vaccinia
infection, including both cellular and vaccinia’s mRNAs,
was affected in general by NSP3. Vaccinia virus infection
itself inhibits host cell protein synthesis, presumably due
to the production of short polyadenylated RNAs
(POLADS). In an in vitro translation system POLADS are
able to inhibit the translation of mRNA from HeLa cells,
but this inhibition is reversed by the addition of PABP.
The translation of vaccinia virus mRNAs, which are also
capped and polyadenylated, is resistant to POLADS pre-
sumably due to less secondary structure at their 5 ends
(Su and Bablanian, 1990). Our data imply that rotavirus
protein NSP3 is able to inhibit the translation of the
mostly capped and polyadenylated mRNAs in vaccinia
infected cells regardless of the presence of POLADS.
The level of NSP3 expression in the vaccinia system
used may be limited by its dependence on the T7 RNA
polymerase. This bacteriophage gene was expressed
from a late vaccinia promoter and as such it is both
FIG. 4. Effect on host cell protein synthesis of wild-type NSP3 and NSP3 with deletions in its RNA-binding (R), dimerization (D), or eIF4G-binding
(4G) domains, expressed from recombinant vaccinia viruses and either noninduced or induced with IPTG. Metabolic [35S]methionine pulse-labeling
of BSC1 cells mock-infected (lane 2) or infected with the vaccinia viruses vT7lacOI (lanes 3 and 4), vRRV7 (lanes 5 and 6), vRRV7-83-149 (lanes 7
and 8), vRRV7-150-206 (lanes 9 and 10), or vRRV7-274-313 (lanes 11 and 12) in the presence or absence of the inducer IPTG (200 M) (added 23 h
prior to labeling) as indicated. [35S]methionine pulse labeling of BSC1 cells infected with vRRV7-83-149 was also performed with a higher dose of
inducer (2000 M) and shorter time of induction (3 h prior to labeling, lane 13). Lane 1 has molecular-weight markers. The solid triangle indicates
the localization of an inducible 25-kDa protein (lane 13).
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capped and polyadenylated (Moss, 2001). We were ac-
cordingly able to detect in pulse-labeling experiments an
inducible 99-kDa protein, presumably the T7 RNA poly-
merase; however, this protein was undetectable in fully
induced cells infected by vRRV7, i.e., its expression was
shut off by NSP3. The effect of NSP3 on the expression
of the T7 RNA polymerase and vice versa may be the
reason why the amount of NSP3 increases in pulse-
labeling experiments with doses of IPTG from 0 to 50 M
and decreases with a higher dose of 200 M. NSP3 is
also expected to affect the expression of the lac repres-
sor in the expression system we used; however, this
effect may be of no significant consequences, since a
high level of the inducer and reduced level of the repres-
sor are expected to operate on the expression system in
the same direction.
Even in the absence of inducer, a condition in which
we did not expect expression of NSP3, we found a
significant 33% reduction of protein synthesis in vRRV7-
infected cells. Expression using the VOTE vaccinia sys-
tem has been described as stringently regulated by hav-
ing the lac operator in both the T7 RNA polymerase and
target genes (Ward et al., 1995). Our data suggest that
there is a low level of expression of NSP3 in this system,
even in the absence of inducer, as evidenced by its effect
on protein synthesis, despite our inability to detect such
a low level of the protein.
The key findings in postulating NSP3 as an inhibitor of
translation of polyadenylated mRNAs were the demon-
stration of its in vitro ability to evict PABP from eIF4G
(Piron et al., 1998) and to do so even in the absence of its
viral mRNA-binding domain (Piron et al., 1999). Likewise
in this study we demonstrated in in vivo experiments that
NSP3 requires its eIF4G-binding domain but not the
RNA-binding domain to shut off host cell protein synthe-
sis. In addition we found that a deletion of the whole
dimerization domain but conserving the eIF4G-binding
domain abolished the inhibitory effect of NSP3 on cellu-
lar protein synthesis, suggesting that NSP3 evicts PABP
from eIF4G as a dimer. We could not directly confirm the
oligomeric status of the recombinant NSP3 due to the
association of a major fraction of the protein with the
cytosqueletal fraction (Mattion et al., 1992) and its ability
to form intramolecular disulfide bridges in vitro (Piron et
al., 1999). The requirement for NSP3 dimerization in order
to evict PABP from eIF4G may arise from a cooperative
effect of the monomeric subunits, as it has been dem-
onstrated for the RNA-binding site on the aminoterminus
of NSP3 (Deo et al., 2002). The deletions of RRV NSP3
used in this study were based on the domains identified
in another group A rotavirus, the bovine virus RF, which
is 84% identical in amino acid sequence, since the re-
gions involved are considered well conserved among
different group A rotaviruses (Rao et al., 1995).
Wild-type NSP3 and its deletion mutants produced in
the VOTE system had the expected molecular weights,
but an additional lower molecular weight protein was
also detected in each case, which may be a product of
proteolytic processing either in vivo or at harvesting.
Since the two fully functional proteins NSP3 and NSP3-
83-149 had such processing, it seems to be irrelevant
for the purpose of this study.
The vaccinia system used allowed high levels of ex-
pression of the NSP3 gene while the global protein
synthesis was shut off, implicating that the shutoff was
selective, allowing the expression of the single EMC
IRES-driven NSP3 gene. Therefore the in vivo expression
from EMC IRES is independent of 5-3 mRNA circular-
ization. This finding is not in agreement with previous in
vitro studies (Michel et al., 2000), where it was found that
addition of a poly(A) tail to an EMC IRES-driven reporter
gene produces a several-fold-stimulated expression in
an in vitro system. These contrasting results may be due
to differences between the in vivo versus in vitro expres-
sion systems. We hypothesize that at least in vivo, IRES
sequences that tolerate modifications in the localization
of the translation initiation codon downstream from an
IRES, like that of poliovirus, require the presence of a 3
polyadenylated tail due to a dependence on the helicase
activity of eIF4A in order to deal with the possible extra
secondary structure of the mRNA, since a known effect
of PABP is the stimulation of the helicase activity of eIF4A
(Bi and Goss, 2000). The in vivo independence on 5-3
mRNA circularization shown in this study for an EMC
IRES-driven gene is consistent with the lack of polyade-
nylation of the EMC virus mRNA, the precision by which
this IRES element direct the initiation of translation to a
single AUG codon, and its proposed mechanism of trans-
lation initiation by direct binding of ribosomes to the
initiating AUG without scanning (Jang and Wimmer,
1990).
MATERIALS AND METHODS
Gene 7 of RRV (accession number x81426) was ampli-
fied from genomic dsRNA with the Thermoscript reverse
transcription–polymerase chain reaction (RT–PCR) sys-
tem (Life Technologies, Gaithersburg, MD) using oligo-
nucleotides RRV7-4 (AATATTCCATGGAGTCTACGCAA-
CAG) and RRV7-313 (ATTAATCTCGAGGATCCTTACTCAT-
AAGTATAAGTGTA) designed to amplify amino acids
4–313 of NSP3. Amino acids 1–3 were excluded from this
construct, since most of the NSP3 produced in infected
cells is expected to lack such amino acids due to the
poor context of the first AUG for translation initiation. The
amplified gene was inserted into the NcoI–BamHI sites
of the plasmid p.VOTE.1 (Elroy-Stein and Moss, 2001).
The resulting plasmid, p.VOTE-RRV7, was used to pro-
duce the recombinant vaccinia virus vRRV7 by homolo-
gous recombination with the parental virus vT7lacOI, as
described (Elroy-Stein and Moss, 2001). In this expres-
sion system, the lacI gene is transcribed from a vaccinia
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early/late promoter, resulting in continuous synthesis of
the E. coli lac repressor which binds to two lacO oper-
ators, one adjacent to a vaccinia virus late promoter
preventing transcription of the bacteriophage T7 RNA
polymerase gene and the second next to a T7 promoter
preventing transcription of the NSP3 gene should leaky
synthesis of the T7 RNA polymerase occur. Upon induc-
tion with IPTG the repressor is inactivated, vaccinia virus
RNA polymerase transcribes the T7 gene, and the poly-
merase is made. The T7 RNA polymerase then tran-
scribes the NSP3 gene, whose translation is enhanced
by the EMC leader.
Deletion mutagenesis of NSP3 from RRV for expres-
sion in the VOTE system was done by PCR. The RNA
binding domain (aa 4–149) was partially deleted by elim-
inating the whole basic region (aa 83–149) (Rao et al.,
1995) using two oligonucleotide pairs, RRV7-4 plus
RRV7-82 (AACTTCACCAATCGCTGAACTAAATT) and
RRV7-150 (CAGCGATTGGTGAAGTTGAAGTT) plus RRV7-
313, to independently amplify the two extremes of the
gene by RT–PCR from genomic dsRNA, combining the
two gene fragments by PCR with oligonucleotides
RRV7-4 and RRV7-313, and then introducing the resulting
fragment into the NcoI–BamHI sites of plasmid p.VOTE-1.
The resulting plasmid, p.VOTE-RRV7-83-149, was then
used to produce the recombinant vaccinia virus vRRV7-
83-149 by homologous recombination. Similarly, a de-
letion eliminating the whole dimerization domain (aa
150–206) was produced by using the two oligonucleotide
pairs, RRV7-4 plus RRV7-149 (GAAGAGAGTACGTTCTA-
ATTTGTCTTTC) and RRV7-207 (TTAGAACGTACTCTCT-
TCCAAAATG) plus RRV7-313, to produce the vaccinia
virus vRRV7-150-206. Finally a deletion of a fragment of
the eIF4G-binding domain consisting of the whole
leucine zipper motif (aa 274–313) (Rao et al., 1995) was
done by amplifying the target region by RT–PCR using
the oligonucleotide pair RRV7-4 and RRV7-273 (GTTG-
GATCCTTAATTTAATTGATCTATTGAA) which was then
used to produce the vaccinia virus vRRV7-274-313.
We performed [35S]methionine labeling experiments of
BSC1 monkey kidney cells and human HeLa cells in-
fected with vaccinia viruses as described (Elroy-Stein
and Moss, 2001), with some modifications. The inducer
was added 1 h postinfection (p.i.) unless otherwise indi-
cated. In extended labeling experiments [35S]methionine
(Pro-mix, Amersham Pharmacia Biotech, Buckingham-
shire, England) was added 2 h p.i. in minimum essential
medium (MEM) containing 1/10th the normal concentra-
tion of unlabeled methionine, and harvesting was done
24 h p.i. Pulse-labeling experiments consisted of a 30-
min pulse started 24 h p.i. (i.e., late in the vaccinia
replication cycle since in the recombinant virus the gene
coding for the bacteriophage T7 RNA polymerase is
transcribed from a late vaccinia promoter). Harvesting of
soluble proteins for RIPAs was done as described (Elroy-
Stein and Moss, 2001), and harvesting of whole cells for
analysis of the metabolically labeled proteins was done
as follows: adherent cells from individual wells in six-
well plates were scraped in 1 ml of ice-cold phosphate-
buffered saline (PBS), divided into two 0.5-ml aliquots,
and microcentrifuged for 1 min at 16,000 g, and the
pellets were resuspended in 20 l of nucleic acid diges-
tion buffer [50 mM Tris (pH 7.5) 5 mM MgCl2, 0.4 U
DNAse I, 50 ng/ml RNAse A, and protease inhibitor
cocktail (P8340, Sigma, St. Louis, MO) used as indicated
by the manufacturer]. The resuspended cells were dis-
rupted for 1 min in a cup sonicator and incubated 10 min
at room temperature to hydrolyze nucleic acids, and the
reaction was stopped with 2.5 l of 100 mM ethylenedi-
aminetetraacetic acid. The digested cells were further
resuspended in Laemli sample buffer and analyzed by
electrophoresis and fluorography. Identical aliquots were
analyzed by electrophoresis and protein staining to
serve as loading controls.
[35S]Methionine-labeled rotavirus proteins were pre-
pared from MA104 cell monolayers infected at an m.o.i.
of 5 with trypsin-activated RRV in serum-free MEM. After
4 h the medium was replaced with methionine-free MEM
containing 100 Ci/ml of [35S]methionine. The cells were
harvested 8 h postinfection in lysis buffer [10 mM Tris
(pH 7.2) 10 mM NaCl, 1.5 mM MgCl2, and 1 mM phenyl-
methylsulfonyl fluoride], diluted one-fold with 2% fetal
bovine serum in MEM, and ultracentrifuged 90 min at
300,000 g to remove viral particles.
RIPA was done in nondenaturing conditions as de-
scribed (Bonifacino et al., 2001) with anti-NSP3 serum or
ascites-fluid-containing monoclonal antibody PNS31.
This serum was produced against NSP3 from the porcine
rotavirus YM fused to glutathione-S-transferase as fol-
lows. A mouse was hyperimmunized with crude antigen
from sonicated bacteria as described (Fuller et al., 2001).
The antigen source was E. coli transformed with the
plasmid pGEX-YM7 (provided by C. Arias, Universidad
Nacional Auto´noma de Me´xico) and induced for NSP3
expression with IPTG as described (Smith and Coroco-
ran, 2001). The hyperimmune mouse was then used to
develop the monoclonal antibody PNS31 (L. Padilla-
Noriega, unpublished results).
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